Trials / Completed
CompletedNCT00726362
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,270 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to survey the efficacy of various commercially available statins (a class of lipid-lowering agents, for example, rosuvastatin, atorvastatin, simvastatin, lovastatin, pravastatin and fluvastatin) under local clinical practice in treating patients with hyperlipidemia. Surveillance data (Lipid Profile) will be collected during course of usual clinical practice or captured upon its availability.
Conditions
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-11-01
- Completion
- 2009-11-01
- First posted
- 2008-07-31
- Last updated
- 2010-12-03
Locations
8 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00726362. Inclusion in this directory is not an endorsement.